Group II metabotropic glutamate receptors enhance NMDA receptor currents via a protein kinase C-dependent mechanism in pyramidal neurones of rat prefrontal cortex

Journal of Physiology

Volumn 554, Issue 3, 2004, Pages 765-777

  Tyszkiewicz, Joanna P ^a   Gu, Zhenglin ^a   Wang, Xun ^a   Cai, Xiang ^a   Yan, Zhen ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; CALCIUM CHELATING AGENT; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIN DEPENDENT KINASE 5; IONOTROPIC RECEPTOR; MAGNESIUM ION; METABOTROPIC RECEPTOR 2; METABOTROPIC RECEPTOR 3; METABOTROPIC RECEPTOR AGONIST; METABOTROPIC RECEPTOR ANTAGONIST; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEIN KINASE C; RECEPTOR SUBUNIT; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; GLUTAMIC ACID; METABOTROPIC RECEPTOR; PHENCYCLIDINE; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN REGION; CENTRAL NERVOUS SYSTEM; COGNITION; CONTROLLED STUDY; DIALYSIS; EMOTION; ENZYME ACTIVITY; ENZYME INHIBITION; MENTAL DISEASE; MODULATION; NONHUMAN; POSTSYNAPTIC MEMBRANE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PYRAMIDAL NERVE CELL; RAT; RECEPTOR UPREGULATION; REGULATORY MECHANISM; ADULT; NEUROMODULATION; SYNAPTIC TRANSMISSION; YOUNG ADULT;

ANIMALS; ELECTRIC CONDUCTIVITY; MICE; MICE, INBRED STRAINS; PHOSPHORYLATION; PREFRONTAL CORTEX; PROTEIN KINASE C; PYRAMIDAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, METABOTROPIC GLUTAMATE; RECEPTORS, N-METHYL-D-ASPARTATE; SIGNAL TRANSDUCTION;

EID: 1242273882     PISSN: 00223751     EISSN: None     Source Type: Journal    
DOI: 10.1113/jphysiol.2003.056812     Document Type: Article

References (66)

1. Andreasen NC, O'leary DS, Flaum M, Nopoulos P, Watkins GL, Boles Ponto LL & Hichwa R (1997). Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naive patients. Lancet 349, 1730-1734.
2. Baskys A & Malenka RC (1991). Agonists at metabotropic glutamate receptors presynaptically inhibit EPSCs in neonatal rat hippocampus. J Physiol 444, 687-701.
3. Behn-Krappa A & Newton AC (1999). The hydrophobic phosphorylation motif of conventional protein kinase C is regulated by autophosphorylation. Curr Biol 9, 728-737.
4. 1A receptors regulate AMPA receptor channels through inhibiting CaMKII in prefrontal cortical pyramidal neurons. J Biol Chem 277, 36553-36562.
5. Carlsson A, Waters N, Holm-Waters S, Tedroff J, Nilsson M & Carlsson ML (2001). Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Annu Rev Pharmacol Toxicol 41, 237-260.
6. Carr DB & Sesack SR (1996). Hippocampal afferents to the rat prefrontal cortex: synaptic targets and relation to dopamine terminals. J Comp Neurol 369, 1-15.
7. Cartmell J & Schoepp DD (2000). Regulation of neurotransmitter release by metabotropic glutamate receptors. J Neurochem 75, 889-907.
8. Chae T, Kwon YT, Bronson R, Dikkes P, Li E & Tsai LH (1997). Mice lacking p35, a neuronal specific activator of cdk5, display cortical lamination defects, seizures, and adult lethality. Neuron 18, 29-42.
9. 2+ block of NMDA-receptor channels as a mechanism of modulation. Nature 356, 521-523.
10. Cho K, Kemp N, Noel J, Aggleton JP, Brown MW & Bashir ZI (2000). A new form of long-term depression in the perirhinal cortex. Nat Neurosci 3, 150-156.
11. Conde F, Marie-Lepoivre E, Audinat E & Crepel F (1995). Afferent connections of the medial frontal cortex of the rat. II. Cortical and subcortical afferents. J Comp Neurol 352, 567-593.
12. Conn PJ & Pin JP (1997). Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol 37, 205-237.
13. Cull-Candy S, Brickley S & Farrant M (2001). NMDA receptor subunits: diversity, development and disease. Curr Opin Neurobiol 11, 327-335.
14. Davis KI, Kahn Rs, Ko G & Davidson M (1991). Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry 148, 1474-1486.
15. Ehlers MD, Zhang S, Bernhardt JP & Huganir RL (1996). Inactivation of NMDA receptors by direct interaction of calmodulin with the NR1 subunit. Cell 84, 745-755.
16. A receptor channels through activation of anchored protein kinase C in prefrontal cortical neurons. J Neurosci 21, 6502-6511.
17. Goldman-Rakic PS (1995). Cellular basis of working memory. Neuron 14, 477-485.
18. Gu Z, Zhong P & Yan Z (2003). Activation of muscarinic receptors inhibits β-amyloid peptide-induced signaling in cortical slices. J Biol Chem 278, 17546-17556.
19. Heidinger V, Manzerra P, Wang XQ, Strasser U, Yu SP, Choi DW & Behrens MM (2002). Metabotropic glutamate receptor 1-induced upregulation of NMDA receptor current: mediation through the Pyk2/Src-family kinase pathway in cortical neurons. J Neurosci 22, 5452-5461.
20. Hellmich MR, Pant HC, Wada E & Battey JF (1992). Neuronal cdc2-like kinase: a cdc2-related protein kinase with predominantly neuronal expression. Proc Natl Acad Sci U S A 89, 10867-10871.
21. Hisatsune C, Umemori H, Inoue T, Michikawa T, Kohda K & Mikoshiba K & Yamamoto T (1997). Phosphorylation-dependent regulation of N-methyl-D-aspartate receptors by calmodulin. J Biol Chem 272, 20805-20810.
22. Hollmann M & Heinemann S (1994). Cloned glutamate receptors. Annu Rev Neurosci 17, 31-108.
23. Jardemark KE, Ninan I, Liang X & Wang RY (2003). Protein kinase C is involved in clozapine's facilitation of N-methyl-D-aspartate- and electrically evoked responses in pyramidal cells of the medial prefrontal cortex. Neuroscience 118, 501-512.
24. Javitt DC & Zukin SR (1991). Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148, 1301-1308.
25. Jentsch JD & Roth RH (1999). The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 20, 201-225.
26. Kingston AE, Ornstein PL, Wright RA, Johnson BG, Mayne NG, Burnett JP, Belagaje R, Wu S & Schoepp DD (1998). LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors. Neuropharmacology 37, 1-12.
27. Klein J, Iovino M, Vakil M, Shinozaki H & Loffelholz K (1997). Ontogenetic and pharmacological studies on metabotropic glutamate receptors coupled to phospholipase D activation. Neuropharmacology 36, 305-311.
28. Lan JY, Skeberdis VA, Jover T, Grooms SY, Lin Y, Araneda RC, Zheng X & Bennett MV & Zukin RS (2001). Protein kinase C modulates NMDA receptor trafficking and gating. Nat Neurosci 4, 382-390.
29. Lewis DA & Lieberman JA (2000). Catching up on schizophrenia: Natural history and neurobiology. Neuron 28, 325-334.
30. Li BS, Sun MK, Zhang L, Takahashi S, Ma W, Vinade L, Kulkarni AB, Brady RO & Pant HC (2001). Regulation of NMDA receptors by cyclin-dependent kinase-5. Proc Natl Acad Sci U S A 98, 12742-12747.
31. 2+-dependent phosphatase. Nature 369, 235-239.
32. Liu F, Ma XH, Ule J, Bibb JA, Nishi A, Demaggio AJ, Yan Z, Nairn AC & Greengard P (2001). Regulation of cyclin-dependent kinase 5 and casein kinase 1 by metabotropic glutamate receptors. Proc Natl Acad Sci U S A 98, 11062-11068.
33. Lovinger DM & Mccool BA (1995). Metabotropic glutamate receptor-mediated presynaptic depression at corticostriatal synapses involves mGluR2 or 3. J Neurophysiol 73, 1076-1083.
34. Lu WY, Xiong ZG, Lei S, Orser BA, Dudek E, Browning MD & Macdonald JF (1999). G-protein-coupled receptors act via protein kinase C and Src to regulate NMDA receptors. Nat Neurosci 2, 331-338.
35. Marek GJ, Wright RA, Schoepp DD, Monn JA & Aghajanian GK (2000). Physiological antagonism between 5-hydroxytryptamine (2A) and group II metabotropic glutamate receptors in prefrontal cortex. J Pharmacol Exp Ther 292, 76-87.
36. Miller EK (1999). The prefrontal cortex: complex neural properties for complex behavior. Neuron 22, 15-17.
37. Mistry R, Golding N & Challiss RA (1998). Regulation of phosphoinositide turnover in neonatal rat cerebral cortex by group I- and II-selective metabotropic glutamate receptor agonists. Br J Pharmacol 123, 581-589.
38. Moghaddam B & Adams BW (1998). Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science 281, 1349-1352.
39. Monyer H, Burnashev N, Laurie DJ, Sakmann B & Seeburg PH (1994). Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12, 529-540.
40. Nakanishi S (1992). Molecular diversity of glutamate receptors and implications for brain function. Science 258, 597-603.
41. Ohishi H, Shigemoto R, Nakanishi S & Mizuno N (1993a). Distribution of the messenger RNA for a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat. Neuroscience 53, 1009-1018.
42. Ohishi H, Shigemoto R, Nakanishi S & Mizuno N (1993b). Distribution of the mRNA for a metabotropic glutamate receptor (mGluR3) in the rat brain: an in situ hybridization study. J Comp Neurol 335, 252-266.
43. Omkumar RV, Kiely MJ, Rosenstein AJ, Min KT & Kennedy MB (1996). Identification of a phosphorylation site for calcium/calmodulin dependent protein kinase II in the NR2B subunit of the N-methyl-D-aspartate receptor. J Biol Chem 271, 31670-31678.
44. Otani S, Daniel H, Takita M & Crepel F (2002). Long-term depression induced by postsynaptic group II metabotropic glutamate receptors linked to phospholipase C and intracellular calcium rises in rat prefrontal cortex. J Neurosci 22, 3434-3444.
45. Petralia RS, Wang YX, Niedzielski AS & Wenthold RJ (1996). The metabotropic glutamate receptors, mGluR2 and mGluR3, show unique postsynaptic, presynaptic and glial localizations. Neuroscience 71, 949-976.
46. Raman IM & Tong G & Jahr CE (1996). Beta-adrenergic regulation of synaptic NMDA receptors by cAMP-dependent protein kinase. Neuron 16, 415-421.
47. Schoepp DD & Conn PJ (1993). Metabotropic glutamate receptors in brain function and pathology. Trends Pharmacol Sci 14, 13-20.
48. Schoepp DD & Jane DE & Monn JA (1999). Pharmacological agents acting at subtypes of metabotropic glutamate receptors. Neuropharmacology 38, 1431-1476.
49. Schoepp DD & Marek GJ (2002). Preclinical pharmacology of mGluR2/3 receptor agonists: novel agents for schizophrenia? Current Drug Targets - CNS Neurol Disorders 1, 215-225.
50. Schoepp DD, Salhoff CR, Wright RA, Johnson BG, Burnett JP, Mayne NG, Belagaje R, Wu S & Monn JA (1996). The novel metabotropic glutamate receptor agonist 2R,4R-APDC potentiates stimulation of phosphoinositide hydrolysis in the rat hippocampus by 3,5-dihydroxyphenylglycine: evidence for a synergistic interaction between group 1 and group 2 receptors. Neuropharmacology 35, 1661-1672.
51. Seeburg PH (1993). The TINS/TIPS lecture: the molecular biology of mammalian glutamate recptor channels. Trends Neurosci 16, 359-365.
52. Strack S & Colbran RJ (1998). Autophosphorylation-dependent targeting of calcium/calmodulin-dependent protein kinase II by the NR2B subunit of the N-methyl-D-aspartate receptor. J Biol Chem 273, 20689-20692.
53. Tanaka C & Nishizuka Y (1994). The protein kinase C family for neuronal signaling. Annu Rev Neurosci 17, 551-567.
54. Tingley WG, Ehlers MD, Kameyama K, Doherty C, Ptak JB, Riley CT & Huganir RL (1997). Characterization of protein kinase A and protein kinase C phosphorylation of the N-methyl-D-aspartate receptor NR1 subunit using phosphorylation site-specific antibodies. J Biol Chem 272, 5157-5166.
55. Tingley WG, Roche KW, Thompson AK & Huganir RL (1993). Regulation of NMDA receptor phosphorylation by alternative splicing of the C-terminal domain. Nature 364, 70-73.
56. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-perret T, Ajakane M, Baudet V, Boissin P, Boursier E, Loriolle F et al. (1991). The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 266, 15771-15781.
57. Tsai G & Coyle JT (2002). Glutamatergic mechanisms in schizophrenia. Annu Rev Pharm Toxicol 42, 165-179.
58. Tsai LH, Delalle I, Caviness VS Jr, Chae T & Harlow E (1994). p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature 371, 419-423.
59. Vicini S, Wang JF, Li JH, Zhu WJ, Wang YH, Luo JH, Wolfe BB & Grayson DR (1998). Functional and pharmacological differences between recombinant N-methyl-D-aspartate receptors. J Neurophysiol 79, 555-566.
60. 4 signaling in prefrontal cortex. J Neurosci 23, 9852-9861.
61. Westphal RS, Tavalin SJ, Lin JW, Alto NM, Fraser ID, Langeberg LK, Sheng M & Scott JD (1999). Regulation of NMDA receptors by an associated phosphatase-kinase signaling complex. Science 285, 93-96.
62. Williams K (1993). Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors. Mol Pharmacol 44, 851-859.
63. Wittmann M, Marino MJ & Conn PJ (2002). Dopamine modulates the function of group II and group III metabotropic glutamate receptors in the substantia nigra pars reticulata. J Pharmacol Exp Ther 302, 433-441.
64. Yan Z, Hsieh-Wilson L, Feng J, Tomizawa K, Allen PB, Fienberg AA, Nairn AC & Greengard P (1999). Protein phosphatase 1 modulation of neostriatal AMPA channels: regulation by DARPP-32 and spinophilin. Nat Neurosci 2, 13-17.
65. A currents in striatal cholinergic interneurons through a PKA/PP1 cascade. Neuron 19, 1115-1126.
66. Zhang S, Ehlers MD, Bernhardt JP, Su CT & Huganir RL (1998). Calmodulin mediates calcium-dependent inactivation of N-methyl-D-aspartate receptors. Neuron 21, 443-453.